Scorpion venom could kill cancer cells

NewsGuard 100/100 Score

When the toxin invades channels in the cells with this disease produces cellular damage until killing them.

In the venom from the Centruroides tecomanus scorpion from Colima, south-west state of Mexico, over a hundred proteins have been found and identified a "possible" toxic effect against cancer cells, reveals a scientific study.

The preliminary investigation is carried out by specialists of the Faculty of Chemistry at the University of Colima (UCOL), who have identified peptides (amino acid molecules) that destroy cancer cells in vitro.

Laura Leticia Valdez Velazquez, head of research, said that when the toxin, derived from scorpion venom, invades channels in the cells with this disease it produces cellular damage until killing them.

"We have identified a highly selective group of peptides, which indicates that they could specifically bind to cancer cells and cause their death," she indicates.

Centruroides tecomanus species is one of the most poisonous scorpions of the country. The UCOL already has the genetic sequences of the protein components of the venom.

The scientific team took advantage of the great number of scorpions found in Colima. They began with the collection and extraction of poison, inoculating and immunizing rabbits as part of the teaching career in Pharmaceutical Chemistry Biologist. From this they decided to study the venom with the support of Lourival Possani, from the Institute of Biotechnology of the National Autonomous University od Mexico (UNAM).

The researcher explains that UCOL undertook the task of characterizing each component from the arachnid toxins, one of the most poisonous of the continent. Currently it has identified a group of peptides (about 10) in order to evaluate the have greater toxic effect against lymphoma cells.

"The venom toxins act on ion channels of the cancer cell damaging them. Our interest is for the cell to be selectively removed. We have found that these peptides have affinity with these cells, that is, they could specifically bind to them and induce cancer death".

In parallel, the research team of the UCOL conducted a study on the effect of scorpion venom in models of Parkinson's disease.

People with this disease (Parkinson's) are affected because neurons are damaged and no dopamine is produced, a neurotramisor responsible for controlling muscle movement. The team has tested the scorpion venom toxins in animal models noting that these toxins are attached to receptors on dopaminergic neurons and increases the release of dopamine, which is displayed with future promising effects for sufferers of this disease.

Although the research is at a primary stage, this is the first time therapy with the venom of scorpions is used against cancer and Parkinson in Mexico.

For the time being, experts have been observed in laboratory animals that the presence of such toxins releases dopamine.

"The idea is that this toxin works for the release of dopamine in Parkinson, condition where there is an absence of the substance. And for cancer we need to know what is the specific peptide, responsible for the effect that causes the death of these cells. The idea is to kill cancer cells; however, this doesn't occur in all types of cancer , there are very specific toxins, that is another task we have to review, see in which type of cancer the toxins have effect, " said Laura Valdez.

The research was supported by the Fund for Strengthening Infrastructure to equip laboratories, granted by the National Council for Science and Technology in Mexico (CONACYT). (Agencia ID)

Comments

  1. Tom Martin Tom Martin United States says:

    How do we keep this venom from killing good cells?

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New cancer projections show increased prostate cases by 25% in 2050, despite prevention efforts